Response to ALA-based PDT in an immortalised normal breast cell line and its counterpart transformed with the Ras oncogen

RODRÍGUEZ, LORENA; DI VENOSA, GABRIELA; BATLLE, ALCIRA; MACROBERT, ALEXANDER; CASAS, ADRIANA

Photochemical and Photobiological Sciences

Royal Society of Chemistry

Año: 2007 vol. 6 p. 1306 - 1310

1474-905X

Aminolevulinic acid (ALA)-based photodynamic therapy (PDT) has been successfully employed in the treatment of certain tumours. Porphyrins endogenously generated from ALA induce tumour regression after illumination with light of an appropriate wavelength. The aim of this work was to compare porphyrin production from ALA and sensitivity to photodynamic treatment in a tumour/normal cell line pair. We employed the HB4a cell line from normal mammary luminal epithelium and its counterpart transfected with the oncogen H-Ras (VAL/12 Ras). After 3 h of exposure to ALA, HB4a-Ras cells produce a maximum of 150 ng porphyrins per 105 cells whereas HB4a produce 95 ng porphyrins per 105 cells. In addition, HB4a-Ras cells show a plateau of porphyrin synthesis at 1 mM whereas HB4a porphyrins peak at the same concentration, and then decrease quickly. This higher porphyrin synthesis in the tumorigenic cell line does not lead to a higher response to the photodynamic treatment upon illumination. Lethal doses 50, LD50, determined by MTT assay were 0.015 J cm-2 and 0.039 J cm-2 for HB4a and HB4a-Ras respectively after 3 h exposure to 1 mM ALA. The conclusion of this work is that a tumour cell line obtained by transfection of the Ras oncogene, although producing higher porphyrin synthesis from ALA, is more resistant to ALA-PDT than the parental non-tumour line, however the mechanism is not related to photosensitiser accumulation, but very likely to cell survival responses.